PROPOFOL VERSUS MIDAZOLAM FOR CONSCIOUS SEDATION ADMINISTERED BY THE NURSE UNDER ENDOSCOPIST’S SUPERVISION IN PATIENTS UNDERGOING ELECTIVE ESOPHAGOGASTRODUODENOSCOPY: THE IMPACT ON ENDOSCOPY UNIT EFFICIENCY

Phase 3

Recruiting

• Conditions: Patients’ characteristics, sedation time, procedure time, RT, EE, adverse events, and patients’ satisfaction; Esophagogastroduodenoscopy, Conscious sedation, Propofol&#44

• Registration Number: TCTR20171127002
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-11-27
• Study Completion: 2018-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Elective esophagogastroduodenoscopy with ASA class I-II and no severe comorbidity

Exclusion Criteria

Severe comorbidity
ASA class III-IV
Pregnancy and Lactating woman

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recovery time Since recovery room arrival to discharge Case record form

Secondary Outcome Measures

Name	Time	Method
Direct cost analysis During procedure Direct cost of EGD and sedation drug